Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 15, Issue 3-4, 2014, Pages 269-274

  Wolf, Joachim ^a   Wöhrle, Johannes C ^b   Palm, Frederick ^a   Nix, Wilfred A ^c   Maschke, Matthias ^d   Safer, Anton ^e   Becher, Heiko ^e   Grau, Armin J ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b Katholisches Klinikum   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Epidemiology; Incidence; Population register

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASCERTAINMENT BIAS; FEMALE; FOLLOW UP; GERMANY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; AGE; EPIDEMIOLOGY; HEALTH CARE PLANNING; MIDDLE AGED; NONPARAMETRIC TEST; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; COMMUNITY HEALTH PLANNING; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; SEX FACTORS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84901500868     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2014.887733     Document Type: Article

References (24)

1. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997. Neurology. 1999;52:504-9
2. Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor neuron disease in Scotland. J Neurol. 2007;254:866-9. (Pubitemid 47222306
3. Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R, et al. Amyotrophic lateral sclerosis in south-east England: A population based study. Neuroepidemiology. 2007;29:44-8
4. Piemonte and Valle d 'A osta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy. Evidence for a uniform frequency in Western countries. Neurology. 2001;56:239-44
5. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. I ncidence of ALS in Lombardy, Italy. Neurology. 2007;68:141-5
6. Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: A population based study. J Neurol Neurosurg Psychiatry. 2005;76:1094-8. (Pubitemid 41081283
7. Huisman MH, d e Jong SW, van Doormaal PT, Weinreich SS, Schelhaas HJ, van der Kooi AJ, et al. Population based epidemiology of amyotrophic lateral sclerosis using capturerecapture methodology. J Neurol Neurosurg Psychiatry. 2011;82:1165-70
8. Murphy M, Quinn S, Young J, Parkin P, Taylor B. I ncreasing incidence of ALS in Canterbury, New Zealand: A 22-year study. Neurology. 2008;71:1889-95
9. McGuire V, Longstreth WT, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington State. Neurology. 1996;47:571-3. (Pubitemid 26324064
10. Statistisches Landesamt Rheinland-Pfalz. Statistics Yearbook of Rhineland-Palatinate 2011 (Statistisches Jahrbuch Rheinland-Pfalz 2011). Bad Ems 2012
11. Ross MA, Miller RG, Berchert L, Parry G, Barohn RJ, Armon C, et al. Toward earlier diagnosis of amyotrophic lateral sclerosis: Revised criteria. Neurology. 1998;50:768-72
12. The ALS CNTF treatment study (ACTS) phase I-II Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol. 1996;53:141-7
13. Hook E, Regal R. C apture-recapture methods in epidemiology: Methods and limitations. Epidemiol Rev. 1995;17:243-64
14. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: New evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6-11
15. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. A myotrophic lateral sclerosis in Olmsted County, Minnesota, 1925-1998. Neurology. 2002;59:280-2
16. Armon C. S moking may be considered an established risk factor for sporadic ALS. Neurology. 2009;73:1693-8
17. Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, et al. Smoking and risk for amyotrophic lateral sclerosis: Analysis of the EPIC cohort. Ann Neurol. 2009;65:378-85
18. Wang H, O ' R eilly EJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ, et al. Smoking and risk of amyotrophic lateral sclerosis: A pooled analysis of fi ve prospective cohorts. Arch Neurol. 2009;68:207-13
19. Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: A 10-year prospective population-based study. Neurology. 2009;72:725-31
20. O' T oole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, Hardiman O. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30-2
21. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586-90. (Pubitemid 41170719
22. Furby A, Beauvais K, Kolev I, Rivain JG, Sebille V. R ural environment and risk factors of amyotrophic lateral sclerosis: A case-control study. J Neurol. 2010;257:792-8
23. Das K, Naq C, Ghosh M. F amilial, environmental, and occupational risk factors in development of amyotrophic lateral sclerosis. N Am J Med Sci. 2012;4:350-5
24. Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, Janssen A, et al. The association between ALS and population density: A population based study. Amyotroph Lateral Scler. 2010;11:435-8.